BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10027012)

  • 21. Putative role of hepatitis B virus X protein in hepatocarcinogenesis: effects on apoptosis, DNA repair, mitogen-activated protein kinase and JAK/STAT pathways.
    Arbuthnot P; Capovilla A; Kew M
    J Gastroenterol Hepatol; 2000 Apr; 15(4):357-68. PubMed ID: 10824878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis B Virus Pre-S2 Mutant Induces Aerobic Glycolysis through Mammalian Target of Rapamycin Signal Cascade.
    Teng CF; Hsieh WC; Wu HC; Lin YJ; Tsai HW; Huang W; Su IJ
    PLoS One; 2015; 10(4):e0122373. PubMed ID: 25909713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between HBV protein preS2 and tumor markers of hepatocellular carcinoma.
    Luan F; Liu B; Zhang J; Cheng S; Zhang B; Wang Y
    Pathol Res Pract; 2017 Sep; 213(9):1037-1042. PubMed ID: 28869105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PreS deletion profiles of hepatitis B virus (HBV) are associated with clinical presentations of chronic HBV infection.
    Li X; Qin Y; Liu Y; Li F; Liao H; Lu S; Qiao Y; Xu D; Li J
    J Clin Virol; 2016 Sep; 82():27-32. PubMed ID: 27415434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro transfection of the hepatitis B virus PreS2 gene into the human hepatocarcinoma cell line HepG2 induces upregulation of human telomerase reverse transcriptase.
    Liu H; Luan F; Ju Y; Shen H; Gao L; Wang X; Liu S; Zhang L; Sun W; Ma C
    Biochem Biophys Res Commun; 2007 Apr; 355(2):379-84. PubMed ID: 17307151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The characteristic changes in hepatitis B virus x region for hepatocellular carcinoma: a comprehensive analysis based on global data.
    Li W; Goto K; Matsubara Y; Ito S; Muroyama R; Li Q; Kato N
    PLoS One; 2015; 10(5):e0125555. PubMed ID: 25942596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular mechanistic insight of hepatitis B virus mediated hepatocellular carcinoma.
    Chaturvedi VK; Singh A; Dubey SK; Hetta HF; John J; Singh MP
    Microb Pathog; 2019 Mar; 128():184-194. PubMed ID: 30611768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic repression of miR-132 expression by the hepatitis B virus x protein in hepatitis B virus-related hepatocellular carcinoma.
    Wei X; Tan C; Tang C; Ren G; Xiang T; Qiu Z; Liu R; Wu Z
    Cell Signal; 2013 May; 25(5):1037-43. PubMed ID: 23376496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differentially expressed genes associated with hepatitis B virus HBx and MHBs protein function in hepatocellular carcinoma.
    Kim DG
    Methods Mol Biol; 2006; 317():141-55. PubMed ID: 16264227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contribution of C1485T mutation in the HBx gene to human and murine hepatocarcinogenesis.
    Hagiwara S; Nishida N; Park AM; Komeda Y; Sakurai T; Watanabe T; Kudo M
    Sci Rep; 2017 Sep; 7(1):10440. PubMed ID: 28874700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Linc00152 promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
    Deng X; Zhao XF; Liang XQ; Chen R; Pan YF; Liang J
    Biomed Pharmacother; 2017 Jun; 90():100-108. PubMed ID: 28343069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of HBV-induced hepatocellular carcinoma.
    Levrero M; Zucman-Rossi J
    J Hepatol; 2016 Apr; 64(1 Suppl):S84-S101. PubMed ID: 27084040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantification of large and middle proteins of hepatitis B virus surface antigen (HBsAg) as a novel tool for the identification of inactive HBV carriers.
    Pfefferkorn M; Böhm S; Schott T; Deichsel D; Bremer CM; Schröder K; Gerlich WH; Glebe D; Berg T; van Bömmel F
    Gut; 2018 Nov; 67(11):2045-2053. PubMed ID: 28951526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative assessment of IgM antibodies towards an immunodominant B-cell epitope within the preS2 domain of HBV in the natural course and during combined prednisone/interferon alpha 2b treatment of chronic hepatitis B virus infection.
    Fei GZ; Sylvan SP; Hellström UB; Yao GB
    J Med Virol; 1995 Jun; 46(2):138-43. PubMed ID: 7636501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HBx triggers either cellular senescence or cell proliferation depending on cellular phenotype.
    Idrissi ME; Hachem H; Koering C; Merle P; Thénoz M; Mortreux F; Wattel E
    J Viral Hepat; 2016 Feb; 23(2):130-8. PubMed ID: 26316075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis B virus X protein inhibits nucleotide excision repair.
    Jia L; Wang XW; Harris CC
    Int J Cancer; 1999 Mar; 80(6):875-9. PubMed ID: 10074921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Naturally Occurring Hepatitis B Virus Mutations Leading to Endoplasmic Reticulum Stress and Their Contribution to the Progression of Hepatocellular Carcinoma.
    Choi YM; Lee SY; Kim BJ
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30704071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of hepatitis B virus integration in hepatitis C virus-infected hepatocellular carcinoma tissues.
    Urashima T; Saigo K; Kobayashi S; Imaseki H; Matsubara H; Koide Y; Asano T; Kondo Y; Koike K; Isono K
    J Hepatol; 1997 Apr; 26(4):771-8. PubMed ID: 9126788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The up-regulation of proteasome subunits and lysosomal proteases in hepatocellular carcinomas of the HBx gene knockin transgenic mice.
    Cui F; Wang Y; Wang J; Wei K; Hu J; Liu F; Wang H; Zhao X; Zhang X; Yang X
    Proteomics; 2006 Jan; 6(2):498-504. PubMed ID: 16317774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B virus X protein promotes hepatocellular carcinoma transformation through interleukin-6 activation of microRNA-21 expression.
    Li CH; Xu F; Chow S; Feng L; Yin D; Ng TB; Chen Y
    Eur J Cancer; 2014 Oct; 50(15):2560-9. PubMed ID: 25087183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.